Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Feito

Showing results (51-60 of 56) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 56 results.
Actas Dermo-Sifiliograficas|April 18, 2026
Management of dermatological adverse events associated with MEK inhibitorsC Prat, Laura Berbegal de Gracia, J Bernabeu-Wittel, et al.
Clinical and Experimental Dermatology|August 26, 2020
Capillary malformation-arteriovenous malformation syndrome: a multicentre studyM Valdivielso-Ramos, A Martin-Santiago, J M Azaña, et al.
The British Journal of Dermatology|September 24, 2020
Prevalence of mucocutaneous manifestations in 666 patients with COVID-19 in a field hospital in Spain: oral and palmoplantar findingsA Nuno-Gonzalez, P Martin-Carrillo, K Magaletsky, et al.
Actas Dermo-Sifiliograficas|May 30, 2021
Baseline description of the Spanish Academy of Dermatology infantile haemangioma nationwide prospective cohort. Comparison of patients treated with propranolol in routine clinical practice with previous pivotal clinical trial dataC Cuenca-Barrales, E Baselga-Torres, J Del Boz-González, et al.
Actas Dermo-Sifiliograficas|July 2, 2013
Prevalence of dystrophic epidermolysis bullosa in Spain: a population-based study using the 3-source capture-recapture method. Evidence of a need for improvement in careA Hernandez-Martín, B Aranegui, M J Escámez, et al.
The British Journal of Dermatology|April 30, 2020
Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 casesC Galván Casas, A Català, G Carretero Hernández, et al.
Pageof 6

Showing results (51-60 of 56) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 56 results.
Actas Dermo-Sifiliograficas|April 18, 2026
Management of dermatological adverse events associated with MEK inhibitorsC Prat, Laura Berbegal de Gracia, J Bernabeu-Wittel, et al.
Clinical and Experimental Dermatology|August 26, 2020
Capillary malformation-arteriovenous malformation syndrome: a multicentre studyM Valdivielso-Ramos, A Martin-Santiago, J M Azaña, et al.
The British Journal of Dermatology|September 24, 2020
Prevalence of mucocutaneous manifestations in 666 patients with COVID-19 in a field hospital in Spain: oral and palmoplantar findingsA Nuno-Gonzalez, P Martin-Carrillo, K Magaletsky, et al.
Actas Dermo-Sifiliograficas|May 30, 2021
Baseline description of the Spanish Academy of Dermatology infantile haemangioma nationwide prospective cohort. Comparison of patients treated with propranolol in routine clinical practice with previous pivotal clinical trial dataC Cuenca-Barrales, E Baselga-Torres, J Del Boz-González, et al.
Actas Dermo-Sifiliograficas|July 2, 2013
Prevalence of dystrophic epidermolysis bullosa in Spain: a population-based study using the 3-source capture-recapture method. Evidence of a need for improvement in careA Hernandez-Martín, B Aranegui, M J Escámez, et al.
The British Journal of Dermatology|April 30, 2020
Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 casesC Galván Casas, A Català, G Carretero Hernández, et al.
Pageof 6